Fred Alger Management, LLC Stoke Therapeutics, Inc. Transaction History

Fred Alger Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$16.8 - $34.15 $100,800 - $204,900	-6,000 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$20.01 - $30.79 $120,060 - $184,740	-6,000 Reduced 50.0%	6,000 $170,000
Q3 2019 Nov 14, 2019	BUY	$20.53 - $37.72 $143,710 - $264,040	7,000 Added 140.0%	12,000 $258,000
Q2 2019 Aug 14, 2019	BUY	$25.53 - $29.17 $127,650 - $145,850	5,000 New	5,000 $146,000

123

57.6M

9.3K

35.2K

Ticker STOK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,419,300
Market Cap $451M
Description
Stoke Therapeutics, Inc., an early-stage biopharmaceutical company, develops novel antisense oligonucleotide (ASO) medicines to treat the underlying causes of severe genetic diseases in the United States. The company utilizes its proprietary Targeted Augmentation of Nuclear Gene Output to design ASOs to precisely upregulate protein expression. I...

Get notified when there are updates to the investment portfolio of Fred Alger Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Fred Alger Management, LLC with notifications on news.